- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
New insights into antigen specific immunotherapy for chronic myeloid leukemia ; volume:12 ; number:1 ; day:15 ; month:12 ; year:2012 ; pages:1-8 ; date:12.2012
Cancer cell international ; 12, Heft 1 (15.12.2012), 1-8, 12.2012
- Creator
-
Li, Yangqiu
- Contributor
-
Lin, Chen
Schmidt, Christian A.
SpringerLink (Online service)
- DOI
-
10.1186/1475-2867-12-52
- URN
-
urn:nbn:de:1111-2016073018923
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Yangqiu
- Lin, Chen
- Schmidt, Christian A.
- SpringerLink (Online service)
Other Objects (12)
Recent developments in immunotherapy of acute myeloid leukemia
MHC-I-presented non-canonical antigens expand the cancer immunotherapy targets in acute myeloid leukemia
Natural killer cell-based immunotherapy for acute myeloid leukemia
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
Chimeric antigen receptor T cells for acute myeloid leukemia
Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Myeloid antigens in childhood lymphoblastic leukemia:clinical data point to regulation of CD66c distinct from other myeloid antigens
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Recent developments in immunotherapy of acute myeloid leukemia
MHC-I-presented non-canonical antigens expand the cancer immunotherapy targets in acute myeloid leukemia
Natural killer cell-based immunotherapy for acute myeloid leukemia
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
Chimeric antigen receptor T cells for acute myeloid leukemia
Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Myeloid antigens in childhood lymphoblastic leukemia:clinical data point to regulation of CD66c distinct from other myeloid antigens
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Recent developments in immunotherapy of acute myeloid leukemia
MHC-I-presented non-canonical antigens expand the cancer immunotherapy targets in acute myeloid leukemia
Natural killer cell-based immunotherapy for acute myeloid leukemia
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
Chimeric antigen receptor T cells for acute myeloid leukemia
Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Myeloid antigens in childhood lymphoblastic leukemia:clinical data point to regulation of CD66c distinct from other myeloid antigens
Chimeric antigen receptor T cell therapies for acute myeloid leukemia